Literature DB >> 19351873

The impact of MRSA on lung function in patients with cystic fibrosis.

Gregory S Sawicki, Lawrence Rasouliyan, Clement L Ren.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19351873     DOI： 10.1164/ajrccm.179.8.734a

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  9 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

Authors:  Marianne Sponer Muhlebach; Valeria Beckett; Elena Popowitch; Melissa B Miller; Arthur Baines; Nicole Mayer-Hamblett; Edith T Zemanick; Wynton C Hoover; Jill M VanDalfsen; Preston Campbell; Christopher H Goss
Journal:  Thorax       Date:  2016-11-15       Impact factor: 9.139

Review 3.  How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?

Authors:  Geraint B Rogers; Kenneth D Bruce; Lucas R Hoffman
Journal:  Curr Opin Pulm Med       Date:  2017-11       Impact factor: 3.155

4.  Optimized In Vitro Antibiotic Susceptibility Testing Method for Small-Colony Variant Staphylococcus aureus.

Authors:  Mimi R Precit; Daniel J Wolter; Adam Griffith; Julia Emerson; Jane L Burns; Lucas R Hoffman
Journal:  Antimicrob Agents Chemother       Date:  2016-01-04       Impact factor: 5.191

Review 5.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

6.  Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis.

Authors:  Daniel J Wolter; Julia C Emerson; Sharon McNamara; Anne M Buccat; Xuan Qin; Elizabeth Cochrane; Laura S Houston; Geraint B Rogers; Peter Marsh; Karandeep Prehar; Christopher E Pope; Marcella Blackledge; Eric Déziel; Kenneth D Bruce; Bonnie W Ramsey; Ronald L Gibson; Jane L Burns; Lucas R Hoffman
Journal:  Clin Infect Dis       Date:  2013-04-26       Impact factor: 9.079

7.  Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.

Authors:  Daniel J Wolter; Frankline M Onchiri; Julia Emerson; Mimi R Precit; Michael Lee; Sharon McNamara; Laura Nay; Marcella Blackledge; Ahmet Uluer; David M Orenstein; Michelle Mann; Wynton Hoover; Ronald L Gibson; Jane L Burns; Lucas R Hoffman
Journal:  Lancet Respir Med       Date:  2019-11-11       Impact factor: 30.700

8.  Update on Epidemiology and Treatment of MRSA Infections in Children.

Authors:  Michael Z David; Robert S Daum
Journal:  Curr Pediatr Rep       Date:  2013-09-01

9.  Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.

Authors:  Kevin J Psoter; Anneclaire J De Roos; Jon Wakefield; Jonathan D Mayer; Margaret Rosenfeld
Journal:  BMC Infect Dis       Date:  2017-06-09       Impact factor: 3.090
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.